Could ‘magic’ mushrooms become medical mushrooms? | Adam Bayes

UNSW Centre for Ideas

More than 264 million people worldwide have depression. But for many people struggling with severe or treatment-resistant depression, standard therapies may not work. So what if there are new treatments that could be effective? Recently there has been a renaissance of interest in psychedelics as possible treatments for mental disorders – everything from ketamine, to MDMA and psilocybin – the psychoactive ingredient in ‘magic’ mushrooms. These medicines have powerful mind-altering properties with the potential to treat severe mental disorders when combined with psychological therapy. Some early studies have returned positive results, but there remain large gaps in our knowledge regarding effectiveness and safety… But where to from here? Could psychedelics play a role in managing mental health?

For more information, visit unsw.to/AdamBayesFODI

This talk was a part of Unthinkable, an event of short talks in the 2022 Festival of Dangerous Ideas.

See omnystudio.com/listener for privacy information.